Neuropathological assessment of Parkinson's disease: refining the diagnostic criteria.
By Dennis W. Dickson, H. Braak, J. Duda, C. Duyckaerts, T. Gasser, G. Halliday, John Hardy, J. Leverenz, K. Del Tredici, Z. Wszolek and 1 more. Lancet Neurology, 2009
867 citations recorded by the source corpus.
Subfields: Neurology
View Paper: https://www.semanticscholar.org/paper/0f95c21187b788e64f516c506eb1b2666ca9aeec
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Neurology
- Dennis W. Dickson
- V. Lee
- John Q. Trojanowski
- E. Masliah
- D. Dexter
- P. Brundin
- Daniel Weintraub
- P. Jenner
Citations in the corpus
- Parkinson disease: from pathology to molecular disease mechanisms. (2013, background): “The role of the Lewy body in pathogenesis remains unknown, but the discovery that misfolded a-synuclein is a major component of the radiating filaments and is also present in neuronal processes as Lewy neurites has altered views on their formation and role in neuronal loss and has led to a major shi”
- Parkinson's disease and parkinsonism: neuropathology. (2012, background): “The combination of Lewy bodies and Lewy neurites is sometimes referred to as Lewy-related pathology (Dickson et al. 2009), because it is increasingly clear that abnormal a-synuclein accumulation in neuronal perikarya may be the tip of the iceberg, with evidence of accumulation not only in neuronal c”
- Past, Present, and Future of Parkinson’s Disease: A Special Essay on the 200th Anniversary of the Shaking Palsy (2017, neutral): “Studies have suggested that reduced heart-rate variability (a marker of cardiac autonomic denervation) may increase risk of PD (with relative risk approximating 2-3).(66,232) Symptoms of bladder dysfunction were associated with an approximately doubled risk of PD in primary care studies.”
- Diagnosis and management of dementia with Lewy bodies (2017, background): “Table 2 also includes an assessment of substantia nigra neuronal loss (none, mild, moderate, and severe) in order to subclassify cases into those likely or not to have parkinsonism (DLB-P and DLB-no P).(60)”
- Mitochondrial Dysfunction in Parkinson's Disease (2011, background): “Parkinson’s disease (PD) is a progressive, neurodegenerative condition characterised by deterioration of the dopaminergic (DA) neurons of the substantia nigra pars compacta (SNpc) [1, 2].”
- Parkinson's disease: genetics and pathogenesis. (2011, background): “A similar scheme of classifying the growing list of genes relevant to PD has been suggested by others (15, 37).”